Zinda Michael (CIK 0001815366)

Latest company ownership

Role: EVP, CHIEF SCIENTIFIC OFFICER
Shares held
80,297
Last filed at
Mar 14, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 12, 2025 Mar 14, 2025 Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Sell 47.5 -5,611 -6.53% $6.4K
Mar 28, 2024 Apr 1, 2024 Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Sell 50.0 -860 -1.18% $4K
Mar 25, 2024 Mar 27, 2024 Repare Therapeutics Inc. EVP, CHIEF SCIENTIFIC OFFICER Sell 50.0 -1,350 -1.82% $6.3K
Jun 7, 2023 Jun 9, 2023 Repare Therapeutics Inc. EVP, Chief Scientific Officer Sell 45.0 -3,535 -2.79% $42.6K
Jun 6, 2023 Jun 7, 2023 Repare Therapeutics Inc. EVP, Chief Scientific Officer Sell 48.8 -1,200 -1.70% $14.4K
Mar 15, 2022 Mar 16, 2022 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 50.0 -533 -1.14% $6K
Nov 15, 2021 Nov 17, 2021 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 7.5 -20,000 -97.40% $546.6K
Aug 16, 2021 Aug 20, 2021 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 7.5 -15,000 -42.21% $509.9K
May 17, 2021 May 18, 2021 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 7.5 -15,000 -29.68% $490.7K
Dec 28, 2020 Dec 30, 2020 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 17.5 -34,744 -40.74% $1.2M
Dec 22, 2020 Dec 28, 2020 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 17.5 -57,979 -10.99% $1.9M
Dec 21, 2020 Dec 22, 2020 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 17.5 -40,000 -31.94% $1.3M
Dec 16, 2020 Dec 18, 2020 Repare Therapeutics Inc. EVP, Chief Science Officer Sell 20.0 -17,277 -4.81% $603.7K